Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabis Therapeutics and the Future of Neurology
Ethan B. Russo
Frontiers in Integrative Neuroscience (2018) Vol. 12
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Cannabinoids: Therapeutic Use in Clinical Practice
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3344-3344
Open Access | Times Cited: 151
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 91
Beyond THC and Endocannabinoids
Pál Pacher, Natalya M. Kogan, Raphael Mechoulam
The Annual Review of Pharmacology and Toxicology (2019) Vol. 60, Iss. 1, pp. 637-659
Closed Access | Times Cited: 144
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms
Ewa Galaj, Guo‐Hua Bi, Hongju Yang, et al.
Neuropharmacology (2019) Vol. 167, pp. 107740-107740
Open Access | Times Cited: 106
Unconventional high-value products from microalgae: A review
Said Abu‐Ghosh, Zvy Dubinsky, Vítor Verdelho, et al.
Bioresource Technology (2021) Vol. 329, pp. 124895-124895
Closed Access | Times Cited: 100
Cannabinoid Regulation of Fear and Anxiety: an Update
Eleni P. Papagianni, Carl W. Stevenson
Current Psychiatry Reports (2019) Vol. 21, Iss. 6
Open Access | Times Cited: 95
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 82
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
Tamara T. Lah, Metka Novak, Milagros A. Pena Almidon, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 340-340
Open Access | Times Cited: 73
It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets
Seyed Alireza Salami, Federico Martinelli, Antonio Giovino, et al.
Molecules (2020) Vol. 25, Iss. 18, pp. 4036-4036
Open Access | Times Cited: 72
Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
Maria de Fátima dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 574-601
Open Access | Times Cited: 14
Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors
Pietro Brunetti, Simona Pichini, Roberta Pacifici, et al.
Medicina (2020) Vol. 56, Iss. 5, pp. 237-237
Open Access | Times Cited: 67
Phytocannabinoid Pharmacology: Medicinal Properties of Cannabis sativa Constituents Aside from the “Big Two”
Peter B. Sampson
Journal of Natural Products (2020) Vol. 84, Iss. 1, pp. 142-160
Closed Access | Times Cited: 51
Characterization of the Cannabis sativa glandular trichome proteome
Lee James Conneely, Ramil Mauleon, Jos C. Mieog, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0242633-e0242633
Open Access | Times Cited: 46
Cannabidiol and substance use disorder: Dream or reality
Saeideh Karimi‐Haghighi, Yasaman Razavi, Daniela Iezzi, et al.
Neuropharmacology (2022) Vol. 207, pp. 108948-108948
Open Access | Times Cited: 33
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
Oluwadara Pelumi Omotayo, Yolandy Lemmer, Shayne Mason
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 8
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and l-DOPA-Induced Dyskinesia
Nilson C. Ferreira‐Junior, Maurício dos Santos Pereira, Francisco Silveira Guimarães, et al.
Neurotoxicity Research (2019) Vol. 37, Iss. 1, pp. 12-29
Closed Access | Times Cited: 44
Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
Ewa Galaj, Zheng‐Xiong Xi
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 134-134
Open Access | Times Cited: 43
Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies
Ana Maria Raymundi, Thiago Rodrigues da Silva, Jeferson Machado Batista Sohn, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 39
Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review
Míriam Mecha, Francisco Carrillo‐Salinas, Ana Feliú, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 34
Development of a novel cannabinoid-loaded microemulsion towards an improved stability and transdermal delivery
Chulhun Park, Jieyu Zuo, Vijay Somayaji, et al.
International Journal of Pharmaceutics (2021) Vol. 604, pp. 120766-120766
Closed Access | Times Cited: 31
Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment
Cristiana Dumbraveanu, Katharina Strommer, Meinolf Wonnemann, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 853-853
Open Access | Times Cited: 13
Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract
Agnese Stanzani, Giorgia Galiazzo, Fiorella Giancola, et al.
Histochemistry and Cell Biology (2020) Vol. 153, Iss. 5, pp. 339-356
Closed Access | Times Cited: 31
Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
Tomasz Charytoniuk, Hubert Żywno, Karolina Konstantynowicz-Nowicka, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4221-4221
Open Access | Times Cited: 28
Medicinal Cannabis and Central Nervous System Disorders
Yuma T. Ortiz, Lance Richard McMahon, Jenny L. Wilkerson
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Lipid nano-carriers loaded with Cannabis sativa extract for epilepsy treatment – in vitro characterization and in vivo efficacy studies
Ljubica Mihailova, Jana Tchekalarova, Dushko Shalabalija, et al.
Journal of Pharmaceutical Sciences (2022) Vol. 111, Iss. 12, pp. 3384-3396
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top